Jazz settles narcolepsy patent row with generics

18-05-2016

Jazz settles narcolepsy patent row with generics

Feng Yu / Shutterstock.com

Jazz Pharmaceuticals has dropped its claims against Ranbaxy, Sun Pharmaceutical and Ohm in a patent infringement case involving  narcolepsy drug Xyrem (sodium oxybate).


Jazz Pharmaceuticals, Ranbaxy, Sun Pharmaceutical, Ohm, Patent, Infringement, Xyrem, ANDA

LSIPR